D. E. Shaw & Co., Inc. Viatris Inc Call Options Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $1.06 Million - $1.21 Million	-80,000 Reduced 86.96%	12,000 $163,000
Q2 2021 Aug 16, 2021	SELL	$12.97 - $16.15 $674,440 - $839,799	-52,000 Reduced 36.11%	92,000 $1.32 Million
Q1 2021 May 17, 2021	SELL	$13.59 - $18.54 $1.02 Million - $1.4 Million	-75,300 Reduced 34.34%	144,000 $2.01 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $3.14 Million - $4.11 Million	219,300 New	219,300 $4.11 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.